Novartis Arthritis Drug Falls Short in Challenge to Global Bestseller Novartis Arthritis Drug Falls Short in Challenge to Global Bestseller
Novartis said a trial fell short of producing statistical evidence that its anti-inflammatory drug Cosentyx (secukinumab) can beat the world's best-selling drug Humira (adalimumab) in treating a type of arthritis.Reuters Health Information
What can serum calprotectin levels tell us about disease activity and severity in inflammatory rheumatic diseases?Arthritis Research &Therapy
(Society of Nuclear Medicine and Molecular Imaging) SNMMI's Virtual Annual Meeting will convene more than 6,000 attendees from around the globe to share novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more.The focus is on precision medicine--improving patients' lives by developing new ways to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient's disease, and monitoring and adjusting treatment to ensure optimum results.
The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare &Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can't self-administer.
Getting on the right treatment plan for your rheumatoid arthritis can help ease the pain that steals your slumber.
Publication date: Available online 6 July 2020Source: Best Practice &Research Clinical RheumatologyAuthor(s): James M. Gwinnutt, Suzanne MM. Verstappen, Jenny H. Humphreys
The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.
The original version of this article was published without open access. With the author(s) ’ decision to opt for Open Choice the copyright of the article changed.]
Abstract Hidradenitis suppurativa is a chronic inflammatory skin disease, which affects 1% of the population, being more common in young, obese and smokers, and mainly affects armpits and groin, with formation of pustules, nodules, abscesses, scars and fistulas. Recently, its association with other autoimmune diseases such as psoriasis, psoriatic arthritis, pyoderma gangrenosum, pyogenic arthritis and ulcerative colitis have been reported. These associated forms are usually resistant to standard treatment, with immunobiologicals as promising therapy. The case of a rare form of association is reported, with only one case pr...
Regeneron Pharmaceuticals and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID-19 patients.Reuters Health Information
ARTHRITIS pain affects about 10 million people in the UK, and can lead to joint pain and inflammation. You could lower your risk of arthritis symptoms and signs by eating certain foods. These are the best spices to protect against joint pain. Should you speak to a doctor about arthritis treatments?